CN Patent

CN101472644B — 递送抗偏头痛化合物的透皮方法和系统

Assigned to Teva Pharmaceuticals International GmbH · Expires 2014-04-23 · 12y expired

What this patent protects

描述了用于递送抗偏头痛化合物的离子电渗贴剂以及使用该贴剂的方法。

USPTO Abstract

描述了用于递送抗偏头痛化合物的离子电渗贴剂以及使用该贴剂的方法。

Drugs covered by this patent

sumatriptan-succinate (SUMATRIPTAN SUCCINATE)

Patent Metadata

Patent number: CN101472644B
Jurisdiction: CN
Classification: —
Expires: 2014-04-23
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceuticals International GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.